BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27190573)

  • 1. Role of Vanadium in Cellular and Molecular Immunology: Association with Immune-Related Inflammation and Pharmacotoxicology Mechanisms.
    Tsave O; Petanidis S; Kioseoglou E; Yavropoulou MP; Yovos JG; Anestakis D; Tsepa A; Salifoglou A
    Oxid Med Cell Longev; 2016; 2016():4013639. PubMed ID: 27190573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: regulation at the interface between regulatory T cells and immune effector cells.
    Esparza EM; Arch RH
    Front Biosci; 2006 May; 11():1448-65. PubMed ID: 16368528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and characterization of novel binary V(V)-Schiff base materials linked with insulin-mimetic vanadium-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Structure-function correlations at the molecular level.
    Halevas E; Tsave O; Yavropoulou MP; Hatzidimitriou A; Yovos JG; Psycharis V; Gabriel C; Salifoglou A
    J Inorg Biochem; 2015 Jun; 147():99-115. PubMed ID: 25920352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.
    Gambhir L; Checker R; Sharma D; Thoh M; Patil A; Degani M; Gota V; Sandur SK
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):297-312. PubMed ID: 26408225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in inflammation and immune responses.
    Contreras J; Rao DS
    Leukemia; 2012 Mar; 26(3):404-13. PubMed ID: 22182919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Losartan suppresses the inflammatory response in collagen-induced arthritis by inhibiting the MAPK and NF-κB pathways in B and T cells.
    Wang X; Chen X; Huang W; Zhang P; Guo Y; Körner H; Wu H; Wei W
    Inflammopharmacology; 2019 Jun; 27(3):487-502. PubMed ID: 30426454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
    Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
    J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
    Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
    Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine receptors are hot in immunopharmacology.
    Akdis CA; Simons FE
    Eur J Pharmacol; 2006 Mar; 533(1-3):69-76. PubMed ID: 16448645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circuitry of nuclear factor kappaB signaling.
    Hoffmann A; Baltimore D
    Immunol Rev; 2006 Apr; 210():171-86. PubMed ID: 16623771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effects of resveratrol and its potential use in therapy of immune-mediated diseases.
    Švajger U; Jeras M
    Int Rev Immunol; 2012 Jun; 31(3):202-22. PubMed ID: 22587021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of tolerogenic dendritic cells by vitamin D receptor agonists.
    Adorini L; Penna G
    Handb Exp Pharmacol; 2009; (188):251-73. PubMed ID: 19031030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine networking of innate immunity cells: a potential target of therapy.
    Striz I; Brabcova E; Kolesar L; Sekerkova A
    Clin Sci (Lond); 2014 May; 126(9):593-612. PubMed ID: 24450743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nuclear factor-kappaB in the immune system and bone.
    Jimi E; Ghosh S
    Immunol Rev; 2005 Dec; 208():80-7. PubMed ID: 16313342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Semin Cancer Biol; 2008 Apr; 18(2):131-40. PubMed ID: 18291670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V
    Fusco L; Gazzi A; Shuck CE; Orecchioni M; Ahmed EI; Giro L; Zavan B; Yilmazer A; Ley K; Bedognetti D; Gogotsi Y; Delogu LG
    Small Methods; 2023 Aug; 7(8):e2300197. PubMed ID: 37291737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.